Introduction to resistance to anticancer agentsKRUH, Gary D.Oncogene (Basingstoke). 2003, Vol 22, Num 47, pp 7262-7264, issn 0950-9232, 3 p.Article

Drug ResistanceKRUH, Gary D.Oncogene (Basingstoke). 2003, Vol 22, Num 47, issn 0950-9232, 294 p.Serial Issue

The MRP family of drug efflux pumpsKRUH, Gary D; BELINSKY, Martin G.Oncogene (Basingstoke). 2003, Vol 22, Num 47, pp 7537-7552, issn 0950-9232, 16 p.Article

Strategies for reversing drug resistanceFOJO, Tito; BATES, Susan.Oncogene (Basingstoke). 2003, Vol 22, Num 47, pp 7512-7523, issn 0950-9232, 12 p.Article

Cisplatin: mode of cytotoxic action and molecular basis of resistanceSIDDIK, Zahid H.Oncogene (Basingstoke). 2003, Vol 22, Num 47, pp 7265-7279, issn 0950-9232, 15 p.Article

The role of p53 in chemosensitivity and radiosensitivityEL-DEIRY, Wafik S.Oncogene (Basingstoke). 2003, Vol 22, Num 47, pp 7486-7495, issn 0950-9232, 10 p.Article

Transcriptional regulation of ABC drug transportersSCOTTO, Kathleen W.Oncogene (Basingstoke). 2003, Vol 22, Num 47, pp 7496-7511, issn 0950-9232, 16 p.Article

Rituximab (monoclonal anti-CD20 antibody): mechanisms of action and resistanceSMITHY, Mitchell R.Oncogene (Basingstoke). 2003, Vol 22, Num 47, pp 7359-7368, issn 0950-9232, 10 p.Article

Resistance to antifolatesRONGBAO ZHAO; GOLDMAN, I. David.Oncogene (Basingstoke). 2003, Vol 22, Num 47, pp 7431-7457, issn 0950-9232, 27 p.Article

Drug methylation in cancer therapy: lessons from the TPMT polymorphismKRYNETSKIL, Eugene; EVANS, William E.Oncogene (Basingstoke). 2003, Vol 22, Num 47, pp 7403-7413, issn 0950-9232, 11 p.Article

Multidrug resistance mediated by the breast cancer resistance protein BCRP (ABCG2)DOYLE, L. Austin; ROSS, Douglas D.Oncogene (Basingstoke). 2003, Vol 22, Num 47, pp 7340-7358, issn 0950-9232, 19 p.Article

Mechanisms of resistance to STI571 in Philadelphia chromosome-associated leukemiasSHAH, Neil P; SAWYERS, Charles L.Oncogene (Basingstoke). 2003, Vol 22, Num 47, pp 7389-7395, issn 0950-9232, 7 p.Article

Alterations in the apoptotic machinery and their potential role in anticancer drug resistanceKAUFMANN, Scott H; VAUX, David L.Oncogene (Basingstoke). 2003, Vol 22, Num 47, pp 7414-7430, issn 0950-9232, 17 p.Article

Transport of amphipathic anions by human multidrug resistance protein 3HAO ZENG; GUOSHENG LIU; REA, Philip A et al.Cancer research (Baltimore). 2000, Vol 60, Num 17, pp 4779-4784, issn 0008-5472Article

Analysis of the MRP4 drug resistance profile in transfected NIH3T3 cellsKUN LEE; KLEIN-SZANTO, Andres J. P; KRUH, Gary D et al.Journal of the National Cancer Institute. 2000, Vol 92, Num 23, pp 1934-1940, issn 0027-8874Article

Dose-Dependent Disposition of Methotrexate in Abcc2 and Abcc3 Gene Knockout Murine ModelsZHAN WANG; QINGYU ZHOU; KRUH, Gary D et al.Drug metabolism and disposition. 2011, Vol 39, Num 11, pp 2155-2161, issn 0090-9556, 7 p.Article

Mechanisms of resistance to topoisomerase I-targeting drugsRASHEED, Zeshaan A; RUBIN, Eric H.Oncogene (Basingstoke). 2003, Vol 22, Num 47, pp 7296-7304, issn 0950-9232, 9 p.Article

The role of glutathione-S-transferase in anti-cancer drug resistanceTOWNSEND, Danyelle M; TEW, Kenneth D.Oncogene (Basingstoke). 2003, Vol 22, Num 47, pp 7369-7375, issn 0950-9232, 7 p.Article

Characterization of the drug resistance and transport properties of multidrug resistance protein 6 (MRP6, ABCC6)BELINSKY, Martin G; CHEN, Zhe-Sheng; SHCHAVELEVA, Irina et al.Cancer research (Baltimore). 2002, Vol 62, Num 21, pp 6172-6177, issn 0008-5472, 6 p.Article

Mechanisms of Taxol resistance related to microtubulesORR, George A; VERDIER-PINARD, Pascal; MCDAID, Hayley et al.Oncogene (Basingstoke). 2003, Vol 22, Num 47, pp 7280-7295, issn 0950-9232, 16 p.Article

Retinoids in cancer therapy and chemoprevention: promise meets resistanceFREEMANTLE, Sarah J; SPINELLA, Michael J; DMITROVSKY, Ethan et al.Oncogene (Basingstoke). 2003, Vol 22, Num 47, pp 7305-7315, issn 0950-9232, 11 p.Article

Physiological and pharmacological functions of Mrp2, Mrp3 and Mrp4 as determined from recent studies on gene-disrupted mice : Transporters in CancerKRUH, Gary D; BELINSKY, Martin G; GALLO, James M et al.Cancer metastasis reviews. 2007, Vol 26, Num 1, pp 5-14, issn 0167-7659, 10 p.Article

Predicting human tumor drug concentrations from a preclinical pharmacokinetic model of temozolomide brain dispositionQINGYU ZHOU; PING GUO; KRUH, Gary D et al.Clinical cancer research. 2007, Vol 13, Num 14, pp 4271-4279, issn 1078-0432, 9 p.Article

Analysis of the drug resistance profile of multidrug resistance protein 7 (ABCC10): Resistance to docetaxelHOPPER-BORGE, Elizabeth; CHEN, Zhe-Sheng; SHCHAVELEVA, Irina et al.Cancer research (Baltimore). 2004, Vol 64, Num 14, pp 4927-4930, issn 0008-5472, 4 p.Article

Role of the tumor microenvironment in mediating de novo resistance to drugs and physiological mediators of cell deathHAZLEHURST, Lori A; LANDOWSKI, Terry H; DALTON, William S et al.Oncogene (Basingstoke). 2003, Vol 22, Num 47, pp 7396-7402, issn 0950-9232, 7 p.Article